when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

AMGEN INC ($AMGN) · catalysts · pharmadog

← back to AMGEN INC

Catalysts for $AMGN

167 tracked

ENBREL (ETANERCEPT) — FDA approval

AMJEVITA (ADALIMUMAB-ATTO) — FDA approval

ENBREL (ETANERCEPT) — FDA approval

ENBREL (ETANERCEPT) — FDA approval

ENBREL (ETANERCEPT) — FDA approval

BLINCYTO (BLINATUMOMAB) — FDA approval

BKEMV (ECULIZUMAB-AEEB) — FDA approval

eculizumab biosimilar

IMDELLTRA (TARLATAMAB-DLLE) — FDA approval

OTEZLA (APREMILAST) — FDA approval

BLINCYTO (BLINATUMOMAB) — FDA approval

WEZLANA (USTEKINUMAB-AUUB) — FDA approval

WEZLANA (USTEKINUMAB-AUUB) — FDA approval

ENBREL (ETANERCEPT) — FDA approval

AMJEVITA (ADALIMUMAB-ATTO) — FDA approval

OTEZLA (APREMILAST) — FDA approval

AMJEVITA (ADALIMUMAB-ATTO) — FDA approval

BLINCYTO (BLINATUMOMAB) — FDA approval

BLINCYTO (BLINATUMOMAB) — FDA approval

ENBREL (ETANERCEPT) — FDA approval

AMJEVITA (ADALIMUMAB-ATTO) — FDA approval

AMJEVITA (ADALIMUMAB-ATTO) — FDA approval

BLINCYTO (BLINATUMOMAB) — FDA approval

ENBREL (ETANERCEPT) — FDA approval

AMJEVITA (ADALIMUMAB-ATTO) — FDA approval

ENBREL (ETANERCEPT) — FDA approval

BLINCYTO (BLINATUMOMAB) — FDA approval

OTEZLA (APREMILAST) — FDA approval

BLINCYTO (BLINATUMOMAB) — FDA approval

BLINCYTO (BLINATUMOMAB) — FDA approval

BLINCYTO (BLINATUMOMAB) — FDA approval

← prevpage 2 of 6next →

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%

$AMGN433.73-1.95%